Merck & Co., Inc. (MRK)
119.30
-3.16
(-2.58%)
USD |
NYSE |
Feb 26, 16:00
119.13
-0.17
(-0.14%)
Pre-Market: 09:08
Merck Free Cash Flow : 12.36B for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 8.10B |
| Biogen, Inc. | 1.969B |
| Regeneron Pharmaceuticals, Inc. | 3.765B |
| Cidara Therapeutics, Inc. (DELISTED) | -132.94M |
| Moderna, Inc. | -2.075B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 2.857B |
| Cash from Investing (Quarterly) | -11.20B |
| Cash from Financing (Quarterly) | 4.751B |
| Free Cash Flow Per Share (Quarterly) | 0.7331 |
| Free Cash Flow to Equity (Quarterly) | -7.336B |
| Free Cash Flow to Firm (Quarterly) | 2.180B |
| Free Cash Flow Yield | 4.13% |